ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008

Abstracts Of Papers Presented By Breast Cancer Task Force

August 27, 1976

In Brief: Thomas Davis, Stanford Oncologist, Dead At 49; DeVita To Visit, NCI; Hunter Named WHI Liaison

September 4, 1992

In Brief: Harvard’s Richmond Said To Be The Choice As Asst. secretary; Lee Clark Convalescing

May 6, 1977